Literature DB >> 26183633

Pulmonary involvement: a rare extraintestinal manifestation of ulcerative colitis.

Jun Nishikawa1, Ayumu Hosokawa, Hiroshi Mihara, Ryuji Hayashi, Shigeharu Miwa, Tatsuhiko Kane, Sohachi Nanjo, Takayuki Ando, Haruka Fujinami, Shinya Kajiura, Masami Minemura, Toshiro Sugiyama.   

Abstract

Ulcerative colitis (UC) is associated with a number of extraintestinal manifestations (EIMs) that may affect most organ systems. Among the EIMs, those involving the lung are rare. We report a case of pulmonary involvement and pyoderma gangrenosum in a patient with refractory UC. A chest computed tomography showed multiple nodular infiltrates in bilateral lungs. The patient had no respiratory symptoms. No infectious agents were detected. A transbronchial biopsy specimen showed nonspecific features. Prednisolone was initiated with significant improvement in the patient's abdominal symptoms and pyoderma gangrenosum. Subsequent imaging after steroid therapy showed improvement of the pulmonary infiltrates. The patient's abdominal symptoms relapsed when prednisolone was tapered. The patient subsequently received a proctocolectomy. Chest radiographs have shown resolution of pulmonary infiltrates. Because pulmonary involvement follows an independent course and a proctocolectomy may not be protective against a recurrence of pulmonary involvement, a careful follow-up should be continued.

Entities:  

Mesh:

Year:  2014        PMID: 26183633     DOI: 10.1007/s12328-014-0473-7

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  14 in total

Review 1.  Pulmonary manifestations of inflammatory bowel disease.

Authors:  Ian Storch; David Sachar; Seymour Katz
Journal:  Inflamm Bowel Dis       Date:  2003-03       Impact factor: 5.325

2.  [Extraintestinal manifestations in inflammatory bowel disease: differences between Crohn's disease and ulcerative colitis].

Authors:  Juan Luis Mendoza; Raquel Lana; Carlos Taxonera; Cristina Alba; Sonia Izquierdo; Manuel Díaz-Rubio
Journal:  Med Clin (Barc)       Date:  2005-09-10       Impact factor: 1.725

3.  Pulmonary toxicity associated with infliximab therapy for ulcerative colitis.

Authors:  S S Heraganahally; V Au; S Kondru; S Edwards; J J Bowden; D Sajkov
Journal:  Intern Med J       Date:  2009-09       Impact factor: 2.048

4.  The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study.

Authors:  C N Bernstein; J F Blanchard; P Rawsthorne; N Yu
Journal:  Am J Gastroenterol       Date:  2001-04       Impact factor: 10.864

5.  A rare extraintestinal manifestation of ulcerative colitis: tracheobronchitis associated with ulcerative colitis.

Authors:  Selen Bayraktaroglu; Ozen Basoglu; Naim Ceylan; Ahmet Aydın; Senay Tuncel; Recep Savas
Journal:  J Crohns Colitis       Date:  2010-07-08       Impact factor: 9.071

Review 6.  Pulmonary manifestations of inflammatory bowel disease: case presentations and review.

Authors:  Benjamin Basseri; Pedram Enayati; Alberto Marchevsky; Konstantinos A Papadakis
Journal:  J Crohns Colitis       Date:  2010-10       Impact factor: 9.071

Review 7.  Thoracic manifestations of inflammatory bowel disease.

Authors:  Hugh Black; Mark Mendoza; Susan Murin
Journal:  Chest       Date:  2007-02       Impact factor: 9.410

Review 8.  Pneumocystis jirovecii pneumonia in non-HIV-infected patients in the era of novel immunosuppressive therapies.

Authors:  Sadatomo Tasaka; Hitoshi Tokuda
Journal:  J Infect Chemother       Date:  2012-08-06       Impact factor: 2.211

9.  Uveitis and erythema nodosum in inflammatory bowel disease: clinical features and the role of HLA genes.

Authors:  Timothy R Orchard; C N Chua; Tariq Ahmad; Hung Cheng; Kenneth I Welsh; Derek P Jewell
Journal:  Gastroenterology       Date:  2002-09       Impact factor: 22.682

Review 10.  The lung in inflammatory bowel disease.

Authors:  P Camus; F Piard; T Ashcroft; A A Gal; T V Colby
Journal:  Medicine (Baltimore)       Date:  1993-05       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.